Back to News
Market Impact: 0.4

Clarivate PLC (CLVT) Q2 Earnings Match Estimates

CLVTNDAQNTNX
Corporate EarningsAnalyst EstimatesCompany FundamentalsCorporate Guidance & OutlookAnalyst InsightsTechnology & InnovationMarket Technicals & FlowsInvestor Sentiment & Positioning
Clarivate PLC (CLVT) Q2 Earnings Match Estimates

Clarivate PLC (CLVT) reported Q2 2025 adjusted EPS of $0.18, aligning with consensus, and revenue of $621.4 million, surpassing estimates by 5.19% despite a year-over-year decline. The company's shares have significantly underperformed the S&P 500 year-to-date, declining 16.7%. With unfavorable estimate revision trends, CLVT currently holds a Zacks Rank #4 (Sell), indicating expected near-term underperformance, a sentiment reinforced by its industry's low ranking.

Analysis

Clarivate PLC's Q2 2025 earnings report presents a mixed but predominantly cautionary picture. While the company surpassed revenue expectations by 5.19%, posting $621.4 million, this figure marks a decline from the $650.3 million reported in the year-ago quarter. Similarly, the adjusted EPS of $0.18 met the Zacks Consensus Estimate but fell short of the $0.20 earned a year prior, indicating contracting profitability. This performance has occurred within a context of significant market underperformance, with CLVT shares declining 16.7% year-to-date against an 8.3% gain for the S&P 500. The negative sentiment is reinforced by an unfavorable trend in earnings estimate revisions leading into the report, culminating in a Zacks Rank #4 (Sell). This suggests continued near-term pressure, a view further supported by the company's placement in the bottom 38% of Zacks-ranked industries. The consensus estimates for the upcoming quarter ($0.16 EPS on $563.84 million revenue) signal expectations of further sequential contraction, making management's commentary on the earnings call a critical determinant for any potential shift in the stock's trajectory.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo